Beryl Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Beryl Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,898,927	Closed	-$6.25M	–	41
2023 Q3	$6.25M	Buy	+4,898,927	New	+$4.28M	0.7%	16

Beryl Capital Management's ZYNE Position: Q4 2023 in Review

Beryl Capital Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 4,898,927 shares — an estimated $6.25M sold.

Beryl Capital Management first reported a position in ZYNE in Q3 2023 and held it in 1 quarter. The position peaked at $6.25M in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Beryl Capital Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Beryl Capital Management sold 4,898,927 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $6.25M.
Beryl Capital Management first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2023 and held it in 1 quarter.
Beryl Capital Management's Zynerba Pharmaceuticals, Inc position peaked at $6.25M in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Beryl Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.